Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum β-lactamase-producing Enterobacteriaceae—a prospective cohort study

Clinical Microbiology and Infection

Volumn 22, Issue 8, 2016, Pages 731.e1-731.e7

  Reuland, E A ^a   Sonder, G J B ^b,c   Stolte, I ^b   al Naiemi, N ^a,d,e   Koek, A ^a   Linde, G B ^f   van de Laar, T J W ^a   Vandenbroucke Grauls, C M J E ^a   van Dam, A P ^f,g  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Laboratory for Medical Microbiology and Public Health   (Netherlands)

^e TWENTEBORG HOSPITAL   (Netherlands)

^f Tropical Medicine and AIDS   (Netherlands)

^g ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Acquisition rate; Ciprofloxacin resistance; Extended spectrum lactamase producing Enterobacteriaceae; Risk factors; Travelling

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAPENEMASE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; NITROFURANTOIN; OFLOXACIN; RANITIDINE; TINIDAZOLE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CITROBACTER FREUNDII; COHORT ANALYSIS; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MIDDLE AGED; MORGANELLA MORGANII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHIGELLA SONNEI; TRAVEL; TRAVELLER DIARRHEA; ASIA; BIOSYNTHESIS; DIARRHEA; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE; RISK FACTOR;

ADULT; ANTI-BACTERIAL AGENTS; ASIA; BETA-LACTAMASES; CIPROFLOXACIN; COHORT STUDIES; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TRAVEL;

EID: 84991108027     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.05.003     Document Type: Article

References (32)

1. [1] Mathai, D., Rhomberg, P.R., Biedenbach, D.J., Jones, R.N., Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn Microbiol Infect Dis 44 (2002), 367–377.
2. [2] Struwe, J., Olsson-Liljequist, B., Short summary of swedres 2008, a report on antimicrobial utilisation and resistance in humans in sweden. Euro Surveill, 14, 2009.
3. [3] Belderok, S.M., van den Hoek, A., Kint, J.A., Schim van der Loeff, M.F., Sonder, G.J., Incidence, risk factors and treatment of diarrhoea among Dutch travellers: reasons not to routinely prescribe antibiotics. BMC Infect Dis, 11, 2011, 295.
4. [4] LCR. National Coordination Center for Travelers Health Available at: https://www.lcr.nl/Landen.
5. [5] World Health Organization. United Nations, Department of Economic and Social Affairs. Available at: http://esa.un.org/unpd/wpp/General/Files/Definition_of_Regions.pdf.
6. [6] Cohen Stuart, J., Leverstein van Hall, M., al Naiemi, N., NVMM guideline laboratory detection of highly resistant microorganisms (HRMO), version 2.0. 2012 Available at: http://www.nvmm.nl/richtlijnen/hrmo-laboratory-detection-highly-resistant-microorganisms.
7. [7] EUCAST. European committee on antimicrobial susceptibility testing Breakpoint tables for interpretation of MICs and zone diameters Available at: http://www.eucast.org/clinical_breakpoints/.
8. [8] Naiemi, N.A., Duim, B., Savelkoul, P.H., Spanjaard, L., de Jonge, E., Bart, A., et al. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43 (2005), 4862–4864.
9. [9] Mulvey, M.R., Bryce, E., Boyd, D.A., Ofner-Agostini, M., Land, A.M., Simor, A.E., et al. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 49 (2005), 358–365.
10. [10] Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2012), 268–281.
11. [11] Kantele, A., Laaveri, T., Mero, S., Vilkman, K., Pakkanen, S.H., Ollgren, J., et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis 60 (2015), 837–846.
12. [12] von Wintersdorff, C.J., Penders, J., Stobberingh, E.E., Oude Lashof, A.M., Hoebe, C.J., Savelkoul, P.H., et al. High rates of antimicrobial drug resistance gene acquisition after international travel, the Netherlands. Emerg Infect Dis 20 (2014), 649–657.
13. [13] Reuland, E.A., Al Naiemi, N., Kaiser, A.M., Heck, M., Kluytmans, J.A., Savelkoul, P.H., et al. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam. J Antimicrob Chemother 71 (2016), 1076–1082.
14. [14] Paltansing, S., Vlot, J.A., Kraakman, M.E., Mesman, R., Bruijning, M.L., Bernards, A.T., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis 19 (2013), 1206–1213.
15. [15] Tangden, T., Cars, O., Melhus, A., Lowdin, E., Foreign travel is a major risk factor for colonization with Escherichia coli producing ctx-m-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 54 (2010), 3564–3568.
16. [16] Laupland, K.B., Church, D.L., Vidakovich, J., Mucenski, M., Pitout, J.D., Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57 (2008), 441–448.
17. [17] Tham, J., Odenholt, I., Walder, M., Brolund, A., Ahl, J., Melander, E., Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 42 (2010), 275–280.
18. [18] Peirano, G., Laupland, K.B., Gregson, D.B., Pitout, J.D., Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med 18 (2011), 299–303.
19. [19] Lubbert, C., Straube, L., Stein, C., Makarewicz, O., Schubert, S., Mossner, J., et al. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol 305 (2015), 148–156.
20. [20] Ruppe, E., Armand-Lefevre, L., Estellat, C., Consigny, P.H., El Mniai, A., Boussadia, Y., et al. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis 61 (2015), 593–600.
21. [21] Hawkey, P.M., Jones, A.M., The changing epidemiology of resistance. J Antimicrob Chemother, 64(Suppl 1), 2009 i3–10.
22. [22] Rossolini, G.M., D'Andrea, M.M., Mugnaioli, C., The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 14:Suppl 1 (2008), 33–41.
23. [23] Beaber, J.W., Hochhut, B., Waldor, M.K., SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427 (2004), 72–74.
24. [24] Woerther, P.L., Burdet, C., Chachaty, E., Andremont, A., Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of ctx-m. Clin Microbiol Rev 26 (2013), 744–758.
25. [25] Kennedy, K., Collignon, P., Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 29 (2010), 1501–1506.
26. [26] Poirel, L., Potron, A., Nordmann, P., Oxa-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67 (2012), 1597–1606.
27. [27] van der Bij, A.K., Pitout, J.D., The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 67 (2012), 2090–2100.
28. [28] Naas, T., Nordmann, P., Oxa-type beta-lactamases. Curr Pharm Des 5 (1999), 865–879.
29. [29] Leverstein-Van Hall, M.A., Stuart, J.C., Voets, G.M., Versteeg, D., Tersmette, T., Fluit, A.C., Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis 10 (2010), 830–831.
30. [30] Kalpoe, J.S., Al Naiemi, N., Poirel, L., Nordmann, P., Detection of an ambler class d OXA-48-type beta-lactamase in a Klebsiella pneumoniae strain in the netherlands. J Med Microbiol 60 (2011), 677–678.
31. [31] Hashimoto, A., Nagamatsu, M., Ohmagari, N., Hayakawa, K., Kato, Y., Kirikae, T., Isolation of OXA-48 carbapenemase-producing Klebsiella pneumoniae ST101 from an overseas traveler returning to Japan. Jpn J Infect Dis 67 (2014), 120–121.
32. [32] Platteel, T.N., Leverstein-van Hall, M.A., Cohen Stuart, J.W., Thijsen, S.F., Mascini, E.M., van Hees, B.C., et al. Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect 21 (2015), 141–146.